Stockreport

Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results [Yahoo! Finance]

Inhibrx Biosciences, Inc.  (INBX) 
PDF Following the completion of the sale of INBRX-101 (the "101 Transaction") by Inhibrx, Inc. (the "Former Parent") to Sanofi S.A. (the "Acquirer") and the Former Parent's [Read more]